Overview

The Effect of Deferasirox on Response Rate of Acute Leukemia Patients Not Treated by Standard Chemotherapy Regimens

Status:
Unknown status

Trial end date:
2016-10-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine whether deferasirox is effective in the treatment of acute lymphatic leukemia (ALL) and acute Myeloid leukemia (AML).

Phase:

Phase 1

Details

Lead Sponsor:

Isfahan University of Medical Sciences

Treatments:

Cytarabine
Deferasirox